The effects of L-carnitine on patients with fatty liver
Xiaohong ZHANG,Ling DU,Weijun GU,Bin SONG,Qiping LIU,Yi TIAN
DOI: https://doi.org/10.3969/j.issn.2095-9400.2015.01.015
2015-01-01
Abstract:Objective: To investigate the effects of L-carnitine on regulating blood lipids, transaminase, hepatic steatosis and fatty of patients with fatty liver.Methods: Dietary intervention with self-control method was adopted in 32 patients with fatty liver living one community. All participants take plus two oral L-carnitine tablets twice a day for three months. Blood lipids, transaminase, hepatic steatosis and fatty prior to intervention were tested and compared to those of after intervention in all participants.Results: After 3 months’ dietary in-tervention, ALT, AST, TBIL, TG, TC, LDL of patients were signiifcantly decreased in contrast to those of prior intervention (P<0.01), while HDL was signiifcantly increased (P<0.01). Body weight, body fat index, waistline, abdominal circumference, hips, waist-hip ratio of all participants were decreasing (P<0.01), respectively, mean-while the subcutaneous fat thickness (arm, back, abdomen) also signiifcantly decreased in contrast to that of prior intervention (P<0.01). Moreover, liver/spleen ratio was signiifcantly increased after intervention (P<0.01), and no side effects was observed in all participants during the trial.Conclusion: As a dietary supplement, L-carnitine can improve the blood lipids, hepatic steatosis, reduce the patient’s transaminase and weight. The dietary inter-vention strategy is convenient and feasible for patients with fatty liver, and also easy for long-term use.